KYBELLA

CONSULTATION REQUIRED     AREA: Jaw, and Neck     FREQUENCY: Every 6-8 weeks     NUMBER OF TREATMENTS: 2-3 for full results

WHAT DOES IT DO?


If you’re looking to get rid of that annoying “double-chin,” KYBELLA™ could be your answer. KYBELLA™ is a prescription injection used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.”

The active ingredient in KYBELLA® is synthetic deoxycholic acid. Deoxycholic acid is a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath the chin, KYBELLA® destroys fat cells, resulting in a noticeable reduction in fullness under the chin. Once destroyed, these cells can no longer store or accumulate fat, so further treatment is not expected once you reach your desired aesthetic goal.

 

FreQuently Asked Questions

 

WHAT TO EXPECT?

Before starting treatment, your healthcare specialist will examine the area under and around your chin to determine if KYBELLA® is right for you. Then, your specialist will tailor your treatment to the amount of fat under the chin and your aesthetic goals.

HOW MANY TREATMENTS WILL I NEED?

Since everyone’s chin profile is different, the number of treatments varies from patient to patient. Your healthcare specialist will help determine how many treatment sessions you need based on the amount and distribution of your submental fat and your personal treatment goals. Each KYBELLA® treatment session is given at least 1 month apart, and you should not receive more than 2-3 treatments.

WILL I NEED TIME TO RECOVER?

After KYBELLA® treatment, you will likely have some swelling, bruising, or numbness under your chin. Be sure to inform your healthcare professional if you develop an uneven smile, facial muscle weakness, difficulty swallowing or injection site problems such as bruising, hair loss, or open sores (ulcers). Call your healthcare provider if you develop open sores or drainage from the treatment area.

WHAT ARE THE POSSIBLE SIDE EFFECTS OF KYBELLA®?

Swelling, pain, numbness, redness, and areas of hardness in the treatment area.

These are not all the possible side effects of KYBELLA®. Call your doctor for medical advice about side effects.

KYBELLA® can cause serious side effects, including

  • Nerve injury in the jaw (which can cause an uneven smile or facial muscle weakness)
  • Trouble swallowing
  • Injection site problems including: bruising, hair loss, open sores (ulcers). Call your healthcare provider if you develop open sores or drainage from the treatment area

WHAT SHOULD I TELL MY DOCTOR BEFORE TREATMENT?

  • Have had or plan to have surgery on your face, neck, or chin
  • Have had cosmetic treatments on your face, neck, or chin
  • Have had or have medical conditions in or near the neck area
  • Have had or have trouble swallowing
  • Have bleeding problems
  • Are pregnant or plan to become pregnant (it is not known if KYBELLA® will harm your unborn baby)
  • Are breastfeeding or plan to breastfeed (it is not known if KYBELLA® passes into your breast milk)
  • Are taking any medications, especially blood thinners

PRE-TREATMENT INSTRUCTIONS

Before receiving KYBELLA®, tell your healthcare provider about all of your medical conditions, including if you: Have had or plan to have surgery on your face, neck, or chin; have had or have medical conditions in or near the neck area; have had or have trouble swallowing; have bleeding problems; are pregnant or plan to become pregnant ; or you are breastfeeding.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take a medicine that prevents the clotting of your blood (antiplatelet or anticoagulant medicine).

POST-TREATMENT INSTRUCTIONS

The most common side effects of KYBELLA® include swelling, bruising, pain, numbness, redness, and areas of hardness in the treatment area. Swelling lasts 1 week, numbness and hardness lasts 4-6 weeks.

So happy with the services I receive at Renew. They are always so welcoming and I feel totally safe with the strategies they use for sanitizing. I would recommend their services to anyone!

Cheryl R

10 June 2020

Dr. Stratte always answers any and all answers you may have. She is very thorough in what she does!



Shelly G

12 February 2021

So sweet and caring. I knew exactly what she was doing. She made me feel so comfortable.

 

Jackie Y

26 March 2021

REQUEST AN APPOINTMENT

Thank you!

Kybella disclaimer

KYBELLA® Professional ISI

INDICATION

KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.

The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.

IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS

KYBELLA® is contraindicated in the presence of infection at the injection sites.

WARNINGS AND PRECAUTIONS

Marginal Mandibular Nerve Injury

Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.

Dysphagia

Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.

Injection-Site Hematoma/Bruising

In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.

Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures

To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles. Care should be taken to avoid inadvertent injection directly into an artery or a vein as it can result in vascular injury.

Injection Site Alopecia

Cases of injection site alopecia have been reported with administration of KYBELLA®. Onset and duration may vary among individuals and may persist. Consider withholding subsequent treatments until resolution.

Injection Site Ulceration and Necrosis

Injections that are too superficial into the dermis may result in skin ulceration and necrosis. Cases of injection site ulceration and necrosis have been reported with administration of KYBELLA®. Do not administer KYBELLA® into affected area until complete resolution.

ADVERSE REACTIONS

The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.

Please see KYBELLA® full Prescribing Information.

KYBELLA® Professional ISI

KYB113214_v2 05/20 005782